These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6115916)

  • 1. Relevance of the rodent area postrema to dopamine-dependent behavioural effects.
    Costall B; Fortune DH; Naylor RJ
    J Pharm Pharmacol; 1981 Apr; 33(4):257-9. PubMed ID: 6115916
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.
    Rebec GV; Peirson EE; McPherson FA; Brugge K
    Psychopharmacology (Berl); 1982; 77(4):360-6. PubMed ID: 6813898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
    Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 5. Function of nigral dopamine receptors?
    Glick SD; Crane LA
    Brain Res; 1978 Nov; 156(2):380-1. PubMed ID: 568507
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
    Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
    Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor sensitivity changes with chronic stimulants.
    Lee TH; Ellinwood EH; Nishita JK
    Ann N Y Acad Sci; 1988; 537():324-9. PubMed ID: 3059930
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of adreno- and dopamine-reactive systems in the central action of caffeine].
    Kurbat NM; Korablev MV
    Farmakol Toksikol; 1981; 44(5):559-61. PubMed ID: 7198054
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO; Vasar EE; Nurk AM; Allikmets LKh
    Farmakol Toksikol; 1985; 48(2):15-8. PubMed ID: 3996566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ethosuximide on dopaminergically mediated behaviours.
    Jadhav JH; Balsara JJ; Jeurkar AJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1981; 25(3):274-8. PubMed ID: 7197666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single and long-term haloperidol administration on open field behavior of rats.
    Bernardi MM; De Souza H; Palermo Neto J
    Psychopharmacology (Berl); 1981; 73(2):171-5. PubMed ID: 6785810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
    White FJ; Hu XT; Brooderson RJ
    Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 20. A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.
    Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
    Life Sci; 1978 Aug; 23(6):545-9. PubMed ID: 692279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.